chr15-100317450-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_139057.4(ADAMTS17):c.616+13439G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0401 in 152,178 control chromosomes in the GnomAD database, including 219 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.040   (  219   hom.,  cov: 32) 
Consequence
 ADAMTS17
NM_139057.4 intron
NM_139057.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.368  
Publications
1 publications found 
Genes affected
 ADAMTS17  (HGNC:17109):  (ADAM metallopeptidase with thrombospondin type 1 motif 17) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. [provided by RefSeq, May 2016] 
ADAMTS17 Gene-Disease associations (from GenCC):
- Weill-Marchesani 4 syndrome, recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Illumina
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0905  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0400  AC: 6081AN: 152060Hom.:  220  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6081
AN: 
152060
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.0401  AC: 6099AN: 152178Hom.:  219  Cov.: 32 AF XY:  0.0399  AC XY: 2969AN XY: 74410 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6099
AN: 
152178
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2969
AN XY: 
74410
show subpopulations 
African (AFR) 
 AF: 
AC: 
3860
AN: 
41516
American (AMR) 
 AF: 
AC: 
304
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
70
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
223
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
136
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
233
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
10
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
1187
AN: 
67984
Other (OTH) 
 AF: 
AC: 
76
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 276 
 552 
 827 
 1103 
 1379 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 70 
 140 
 210 
 280 
 350 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
113
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.